Breaking News

You are here » Indian-Commodity  :  Commodities  :  Other Commodities  :  Nickel futures edge down on subdued demand

30-Apr2018

Nickel futures edge down on subdued demand

Nickel futures edged down on MCX as participants offloaded their holdings, tracking subdued demand from alloy-makers and other consuming industries at the spot market.

The contract for April delivery was trading at Rs 921.20, down by 0.24% or Rs 2.20 from its previous closing of Rs 923.40. The open interest of the contract stood at 6121 lots.

The contract for May delivery was trading at Rs 921.00, down by 0.53% or Rs 4.90 from its previous closing of Rs 925.90. The open interest of the contract stood at 5521 lots on MCX.


Related News

View all news

Barley futures trade higher on rise in demand

Barley futures trade higher on NCDEX, with the enlarged position building by the speculators as well as rise in physical demand from breweries.The contract for January delivery was trading at 1943.00,......

Barley futures trade modestly lower on dip in demand

Barley futures trade modestly lower on NCDEX, due to liquidation of bets at prevailing higher rates with dip in spot demand from beer makers.The contract for April delivery was trading at 1650.00, down......

Nickel futures edge higher on improved demand

Nickel futures edged higher on MCX as participants enlarged their holdings, tracking improved demand from alloy-makers and other consuming industries at the domestic spot market. The contract for January......

Top News

View all news

RPP Infra Projects bags orders worth Rs 62.90 crore from BHEL

RPP Infra Projects has bagged orders from Bharat Heavy Electricals (BHEL), Chennai for worth of Rs 62.90 crore. The first order is for providing civil works of Boiler, Mill and Bunker, ESP area of unit......

Glenmark gets tentative ANDA approval for Abiraterone Acetate Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate Tablets USP, 250 mg, a generic......

HDFC Standard Life Insurance reports 18% rise in Q3 net profit

HDFC Standard Life Insurance has reported results for third quarter ended December 31, 2018. The company has reported a rise of 18.48% in its net profit at Rs 245.63 crore for the quarter under review......